Muscle Tone clinical trials

Explore recruiting muscle tone clinical trials.

Recruiting muscle tone studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Muscle Tone trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Comparison of multiple doses of intramuscular versus intranasal naloxone for reversal of opioid toxicity

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport®) in Comparison with OnabotulinumtoxinA (Botox®) when Treating Adults with Upper Limb Spasticity

France

Therapeutic use (Phase IV) EU CTIS Study details

An Integrated Phase I/II, Multicentre, Double-Blind, Randomised, Dysport and Placebo Controlled, Dose-Escalation and Dose-Finding Study to Evaluate the Safety and Efficacy of IPN10200 in the treatment of Adult Upper Limb Spasticity Followed by an Open-label Extension Period

Bulgaria, Poland, Austria, Czechia, Germany, Spain +4 more

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Phase IV, multicenter, open-label, single-arm, open-label study to evaluate the safety of almagate in pregnant women with acidity and heartburn, and on perinatal outcomes in the fetus and newborn

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A phase II randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of an oral solution of 9-Δ tetrahydrocannabinol/cannabidiol (THC/CBD) in multiple sclerosis patients with chronic neuropathic pain

Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

Muscle Tone trials by city

Muscle Tone in Toronto Muscle Tone in Vancouver Muscle Tone in Montreal Muscle Tone in Calgary Muscle Tone in Edmonton Muscle Tone in Ottawa Muscle Tone in Winnipeg Muscle Tone in Quebec City Muscle Tone in Hamilton Muscle Tone in Kitchener Muscle Tone in London Muscle Tone in Halifax Muscle Tone in New York Muscle Tone in Los Angeles Muscle Tone in Chicago Muscle Tone in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease